C-Rad AB (LTS:0R44) Net Margin % : 13.56% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is C-Rad AB Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. C-Rad AB's Net Income for the three months ended in Mar. 2024 was kr16.0 Mil. C-Rad AB's Revenue for the three months ended in Mar. 2024 was kr118.0 Mil. Therefore, C-Rad AB's net margin for the quarter that ended in Mar. 2024 was 13.56%.

The historical rank and industry rank for C-Rad AB's Net Margin % or its related term are showing as below:

LTS:0R44' s Net Margin % Range Over the Past 10 Years
Min: -37.76 Med: -2.12 Max: 11.15
Current: 10.53

LTS:0R44's Net Margin % is ranked better than
74.36% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -1.64 vs LTS:0R44: 10.53

C-Rad AB Net Margin % Historical Data

The historical data trend for C-Rad AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C-Rad AB Net Margin % Chart

C-Rad AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-6.72

6.48

9.61

2.48

8.37

C-Rad AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Margin %	Get a 7-Day Free Trial															3.79	5.96	9.80	11.51	13.56

Competitive Comparison of C-Rad AB's Net Margin %

For the Medical Devices subindustry, C-Rad AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

C-Rad AB's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where C-Rad AB's Net Margin % falls into.

C-Rad AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

C-Rad AB's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	35.529	/	424.615
	=	8.37 %

C-Rad AB's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin	=	Net Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	16	/	118
	=	13.56 %

C-Rad AB (LTS:0R44) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

C-Rad AB Net Margin % Related Terms

Thank you for viewing the detailed overview of C-Rad AB's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

C-Rad AB (LTS:0R44) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » C-Rad AB (LTS:0R44) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

CRAD B:Sweden 24C:Germany

Address

Sjukhusvägen 12K, Uppsala, SWE, 753 09

Website

https://www.c-rad.com

C-Rad AB is a Sweden based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. The operating segments of the group are the Positioning segment which includes development and sales of products in the field of patient positioning during radiotherapy, including catalyst, sentinel, and HIT lasers; and the Imaging segment which includes the development of imaging devices and detectors for cancer treatments and dosimetry. It generates maximum revenue from the Positioning segment. The firm sells its products in Sweden and internationally.

C-Rad AB (LTS:0R44) Headlines

No Headlines